Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial.
Emmy M Trinks-RoerdinkGeert-Jan GeersingCarline J van den DriesMartin E W HemelsMichiel RienstraIsabelle C van GelderMaarten van SmedenDavid van KlaverenDavid M KentFrans H RuttenSander van DoornPublished in: PloS one (2023)
While the relative degree of benefit from integrated AF care is similar in all patients, patients with a high all-cause mortality risk have a greater benefit on an absolute scale and should therefore be prioritized when implementing integrated care.